Drugs and Pharmaceuticals
ثبت نشده
چکیده
منابع مشابه
مقایسه نظام قیمت گذاری و بیمه دارو در ایران و کشورهای منتخب
Introduction: Pharmaceuticals comprise a large portion of health care expenditures, including insurance organizations expenditures. Accumulated evidence suggests that the inefficiencies of Iran's health insurance structure have led to soaring out- of- pocket payments by the beneficiaries of health insurance organizations. This study was conducted to compare pricing and reimbursement of pharmace...
متن کاملEssential drugs and registration of pharmaceuticals: the Sri Lankan experience.
Many factors influence the regulation of pharmaceuticals in a country. The essential drugs concept, formulated by the World Health Organization to assist developing countries in selecting appropriate drugs, also provides a basis for regulation. Sri Lanka has long regulated pharmaceuticals as part of its health policy. Over 70% of 3436 pharmaceutical product registrations were found to be drugs ...
متن کاملRemoval of Pharmaceutical Compounds from Hospital Wastewaters Using Nanomaterials: A Review
Over the past few years, residual pharmaceuticals (antibiotics, anticonvulsants, antipyretics drugs, hormones) have begun to be considered as emerging environmental pollutants due to their continuous input and persistence to aquatic ecosystem even at low concentrations. Therefore, the development of efficient, cost-effective, and stable methods and materials for the wastewaters treatment have g...
متن کاملUsing Investigative Analytics to Speed New Drugs to Market
A shortage of new blockbuster drugs and the expiration of patents on older drugs together leave pharmaceuticals companies struggling to maintain sales and profits. Meanwhile, regulatory agencies, particularly in the U.S. and Europe, are increasingly relying on new analytic and information tools to meet pressure to approve breakthrough drugs more quickly. The more quickly and efficiently pharmac...
متن کاملUsing Investigative Analytics to Speed New Drugs to Market
A shortage of new blockbuster drugs and the expiration of patents on older drugs together leave pharmaceuticals companies struggling to maintain sales and profits. Meanwhile, regulatory agencies, particularly in the U.S. and Europe, are increasingly relying on new analytic and information tools to meet pressure to approve breakthrough drugs more quickly. The more quickly and efficiently pharmac...
متن کاملEssential Drugs Production in Brazil, Russia, India, China and South Africa (BRICS): Opportunities and Challenges
The objective of this work is to elucidate various essential drugs in the Brazil, Russia, India, China and South Africa (BRICS) countries. It discusses the opportunities and challenges of the existing biotech infrastructure and the production of drugs and vaccines in member states of the BRICS. This research is based on a systematic literature review between the years 2000 and 2014 of documents...
متن کامل